Does he have a deal similar to the new hires, who get 100,000 shares each if the company is sold?
If so, not much reason to buy anyway.
I'd like to know if the regular employees are buying.
Yeah, not much of a confidence booster from someone who earns at least 375k a year. If officers are really that confident of Isonep success, you would think that they would be risking as much as the INO CEO's $2.2M buy. Still better than none.
Do you mean OPTO7825? I guess you just don't appreciate my sense of humour. I would have come up with something much more relevant and clever than "Pizza delivery boy"
I am not going to badmouth any purchase by an insider (I am honestly shocked they bought any at all) but considering we had more than 600K shares move over the last three days, these are fairly meager purchases. I bought more than the CFO. And why not earlier when we started this drop? Maybe we could have avoided this recent dump altogether. Just saying.
I also really want to know who our seller was. No Form 4? We move to Delaware and suddenly someone exits a huge position over a couple of days without even trying to manage price and there is no reporting? Who does something like that? Someone flying very close under the radar...
While generally I am opposed to management talking out of turn here, I think this deserves some kind of attention. A few 100k here and there is one thing but a movement like this should have some scrutiny.
My Neighbor ordered a pizza from Domino's last night and guess who was the delivery boy?
That's right, Scott is getting ready for his next career. I am taking a few days off at the request of my friend John. He opened my eyes to Scotty the snake so I owe him at least that.
Sentiment: Strong Sell
Good question, "the sheet is jacked up". I get nothing from google.
CEZERO I get, assume he meant way to go, not why to go.
but the last half of that i get no meaning from
Even a rookie like me can see that the sheet is jacked up. I'm tempted to sell right now. Why to go CEZERO step up to the plate when the girls starts pitching.
If there were 2 arms in the trial, one with avastin and one with Isonep, then if half the people were doing super great and half were not, then they may assume it must be Isonepm and unblind, We have at least 4 arms , Isonep low dose, high dose, isonep with Avastin, Isonep with Eyelea, multiple drugs and varying doses, makes it harder to see a pattern like that.
The whole point of the double blind is to avoid bias and as such, supposedly no one knows who is getting what and there would be no information anyone could use to make the determination to halt the trials. I believe that there are very strict guidelines you have to follow to make this type of study valid so I don't think deviations or modifications are allowed either.
We were also told that the reason it was taking so long to get to full enrollment is because they were having a very high rejection rate for the candidates being submitted for the study. North of 80% if I remember right. I am not aware of any update to that but assuming all of this is legit, it explains everything.
I am not the expert on this but this is my understanding of why we are seeing what we are seeing with the trials. At least on the surface it makes sense to me.